Long-Term Use of Mesalamine (Rowasa) Suppositories in Remission Maintenance of Ulcerative Proctitis
Stephen B. Hanauer(Northwestern University), Malcolm Robinson(St John of God Subiaco Hospital), Ronald J Pizinger(Scripps Clinic), Noel C. Williams(Presbyterian Hospital), Gregory Haber(NYU Langone Health), Michael W Goodman(Presbyterian Hospital), Williamson B. Strum(Scripps Clinic), Larry Good(Presbyterian Hospital), Carl Lyss(University of Chicago Medical Center)
Cited by 101
Related Papers
Eosinophilic esophagitis in a patient with vigorous achalasia
|Gastroenterology|1978|437
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and <i>IBD1</i>
|Proceedings of the National Academy of Sciences|1998|384
Colorectal Adenomas
|New England Journal of Medicine|2016|307
Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study
|Clinical Gastroenterology and Hepatology|2013|292
Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort
|The American Journal of Gastroenterology|2006|289